Abstract
A critical appraisal and clinical application of Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2014;125(6):924-929. doi: 10.1182/blood-2014-09-599498.
DOI
10.22237/crp/1568851260
Recommended Citation
BRAZIER AJ Jr. Fondaparinux is an effective alternative to other non-heparin anticoagulants in the treatment of heparin-induced thrombocytopenia. Clin. Res. Prac. 2019 Oct 1, 5(2):eP1875. doi: 10.22237/crp/1568851260
Included in
Medical Education Commons, Medical Pharmacology Commons, Translational Medical Research Commons
